Skip to main content
. 2017 Sep 13;8(55):94910–94919. doi: 10.18632/oncotarget.20862

Figure 4. Sensitivity analysis of included studies examining the TNF-α promoter -308 A/G polymorphism and sepsis risk (CC vs. CG + GG).

Figure 4